Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic HBV vaccine in chronic hepatitis B
NCT03038802Phase 2Not yet recruiting
- Sponsor
- Vaxine
- Start
- Mar 2026
- Primary completion
- Mar 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Hepadvax in Chronic Hepatitis B (CHB), sponsored by Vaxine. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
Hepadvax
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03038802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03038802.